Protein Summary
Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or ZN(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity). The protein encoded by this gene is a membrane glycosylphosphatidylinositol-anchored glycoprotein that tends to aggregate into rod-like structures. The encoded protein contains a highly unstable region of five tandem octapeptide repeats. This gene is found on chromosome 20, approximately 20 kbp upstream of a gene which encodes a biochemically and structurally simila ...more
- ENST00000379440
- ENSP00000368752
- ENSG00000171867
- ENST00000430350
- ENSP00000399376
- ALTPRP
- PRIP
- PRP
- CJD
- GSS
- PrP
- ASCR
- KURU
- PRIP
- PrPc
- CD230
- AltPrP
- p27-30
- PrP27-30
- PrP33-35C
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
biological term | 1 | ||
kinase perturbation | 1 | ||
transcription factor perturbation | 0.98 | ||
disease perturbation | 0.97 | ||
biological process | 0.96 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6045.53 (req: < 5)
Gene RIFs: 668 (req: <= 3)
Antibodies: 706 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6045.53 (req: >= 5)
Gene RIFs: 668 (req: > 3)
Antibodies: 706 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 59
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 12
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 1